Primary Biliary Cirrhosis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on "Primary Biliary Cirrhosis - Market Insights, Epidemiology, and Market Forecast-2030".
DelveInsight's "Primary
Biliary Cirrhosis - Market Insights, Epidemiology, and Market Forecast-2030" report
delivers an in-depth understanding of the Primary Biliary Cirrhosis, historical
and forecasted epidemiology as well as the Primary Biliary Cirrhosis market
trends in the United States, EU5 (Germany, Spain, Italy, France, and United
Kingdom) and Japan.
·
According to American Association for the Study
of Liver Diseases (AASLD), in 2016, the prevalence of PBC in the U.S. was
estimated to vary from 1.91 to 40.2 per 100,000 persons
·
In UK, the prevalence of PBC is estimated to be
12.9 per 100,000 population, of which 90% of cases where reported in women
·
Epidemiological studies also revealed the
prevalence of PBC to be around 27–54 per million cases in Japan
·
As per one study conducted by Daniel S. Smyk
(February 2012), approximately 7–11% of PBC patients are males.
View Report: https://www.delveinsight.com/report-store/primary-biliary-cirrhosis-market
Request for free
report: https://www.delveinsight.com/sample-request/primary-biliary-cirrhosis-market
- The
report covers the descriptive overview of Primary Biliary Cirrhosis,
explaining its causes, signs and symptoms, pathophysiology, diagnosis and
currently available therapies
- Comprehensive
insight has been provided into the Primary Biliary Cirrhosis epidemiology
and treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Primary Biliary Cirrhosis are provided, along with the assessment of new
therapies, which will have an impact on the current treatment landscape
- A
detailed review of Primary Biliary Cirrhosis market; historical and
forecasted is included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Primary Biliary
Cirrhosis market
Primary
Biliary Cirrhosis (PBC) is a chronic, progressive liver
disorder that mostly affects women and usually appears during middle age. It
leads to inflammation and scarring of the small bile ducts. If PBC is
untreated, it can lead to cirrhosis, or scarring of the entire liver, which can
lead to liver failure.
PBC is divided into four stages with stage 1 being early
disease, where this is no significant scarring, to stage 4, which is defined by
cirrhosis.
The most common symptom of PBC is fatigue. When PBC is very
severe, it can lead to yellow discoloration of the skin (jaundice).
PBC is common among women of middle age worldwide. The
disease ratio among female to male is 9:1.
View Report: https://www.delveinsight.com/report-store/primary-biliary-cirrhosis-market
Request for free
report: https://www.delveinsight.com/sample-request/primary-biliary-cirrhosis-market
·
Axcan Pharma
·
Intercept Pharmaceuticals
·
Calliditas Therapeutics
·
CymaBay Therapeutics
·
Fast Forward Pharmaceuticals
·
Genkyotex
·
And Many Others
·
Ursodeoxycholic acid
·
Obeticholic acid
·
NEFECON
·
Seladelpar
·
FFP104
·
GKT831
·
And Many Others
View Report: https://www.delveinsight.com/report-store/primary-biliary-cirrhosis-market
Request for free
report: https://www.delveinsight.com/sample-request/primary-biliary-cirrhosis-market
1. Key Insights
2. Executive Summary
of Primary Biliary Cirrhosis
3. Competitive
Intelligence Analysis for Primary Biliary Cirrhosis
4. Primary Biliary
Cirrhosis: Market Overview at a Glance
4.1. Primary Biliary Cirrhosis Total Market Share (%)
Distribution in 2017
4.2. Primary Biliary Cirrhosis Total Market Share (%)
Distribution in 2030
5. Primary Biliary
Cirrhosis: Disease Background and Overview
6. Patient Journey
7. Primary Biliary
Cirrhosis Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
8.1. Primary Biliary Cirrhosis Treatment and Management
8.2. Primary Biliary Cirrhosis Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of
Primary Biliary Cirrhosis Treatment
11. Marketed
Products
List to be continued in report
12. Emerging
Therapies
List to be continued in report
13. Primary Biliary
Cirrhosis: Seven Major Market Analysis
13.1. Key Findings
13.2. Primary Biliary Cirrhosis Market Size in 7MM
13.3. Primary Biliary Cirrhosis Market Size by Therapies in
the 7MM
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Primary Biliary Cirrhosis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
View Report: https://www.delveinsight.com/report-store/primary-biliary-cirrhosis-market
Request for free
report: https://www.delveinsight.com/sample-request/primary-biliary-cirrhosis-market
About DelveInsight
DelveInsight is a premier Business Consulting and Market
Research firm focused exclusively on the life science segment. With a wide
array of smart end-to-end solutions, the firm helps the global Pharmaceutical
and Bio-Tech companies formulate prudent business decisions for
Browse through our vast repository from here.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment